Latest News

HPV vaccine effectiveness dependent on age at receipt


 

FROM JAMA NETWORK OPEN

Vaccination rates increasing

Asked to comment on the findings, Rebecca Perkins, MD, professor of obstetrics and gynecology at Boston University, Boston Medical Center, pointed out that the investigators evaluated data from 2011 to 2018. “We know that HPV vaccination rates have increased over that period and continue to increase,” she emphasized in an email to this news organization.

Physicians also know that more persons are being vaccinated between the ages of 9 and 12 than was the case at the beginning of this study. “This is good news,” she said, “as it means that more adolescents now in 2022 are benefiting fully from vaccination than they were in 2011,” she added.

At the same time, Dr. Perkins acknowledged that many persons are still missing out on the chance to receive the vaccine on time – which means they are missing out on the chance to prevent cancer.

“Making sure that all adolescents receive vaccination between the ages of 9 to 12 has the potential to prevent up to 40,000 cancers every year in the U.S., [including] the most common HPV-related cancers, such as cervical cancer in women and tongue and tonsillar cancer in men,” Dr. Perkins noted.

“Thus, it’s critical that doctors and parents get the message that you can’t vaccinate too early, only too late,” she emphasized.

Dr. Edgman and Dr. Perkins report no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Study confirms increased CVT with AstraZeneca COVID vaccine
MDedge Hematology and Oncology
FDA grants emergency authorization for Novavax COVID vaccine
MDedge Hematology and Oncology
Amazon involved with new cancer vaccine clinical trial
MDedge Hematology and Oncology
Single dose of HPV vaccine is ‘game changer,’ says WHO
MDedge Hematology and Oncology
Should patients undergoing surgical treatment for cervical lesions also receive an HPV vaccination?
MDedge Hematology and Oncology
Malaria vaccine gets special delivery by tiny health personnel
MDedge Hematology and Oncology
HPV infection in pregnancy higher among women living with HIV
MDedge Hematology and Oncology
For many, long COVID’s impacts go on and on, major study says
MDedge Hematology and Oncology
You and the skeptical patient: Who’s the doctor here?
MDedge Hematology and Oncology
Original COVID-19 vaccines fall short against Omicron subvariants for the immunocompromised
MDedge Hematology and Oncology